Date of announcement
2021/06/11
Time of announcement
19:32:19
Date of events
2021/06/11
To which item it meets
paragraph 24
Statement
1.Name and nature of the underlying security (if preferred shares, the terms
and conditions of issuance shall also be indicated, e.g., dividend yield):
Partnership interests in「CDIB-Kunshan Taiwanese Business Fund」(tentative name)
2.Date of occurrence of the event: 2021/06/11
3.No., unit price, and monetary amount of the transaction:
No., unit price: Not applicable; total monetary amount of the transaction:
up to 5% (inclusive) of the final closing amount of the fund or RMB 50
million, whichever is lower.
4.Counterparty to the trade and its relationship to the company (if the
trading counterparty is a natural person and not a related party of the
company, its name is not required to be disclosed):
Counterpart：A new investment in「CDIB-Kunshan Taiwanese Business Fund」
Its relationship to the Company：it is not a related party of financial
statement report.
5.Where the counterparty to the trade is a related party, an announcement
shall also be made of the reason for choosing the related party as trading
counterparty and the identity of the previous owner, including its
relationship with the company and the trading counterparty, the price of the
ownership transfer, and date of transfer: Not applicable
6.Where the owner of the underlying securities within the past five years
has been a related party of the company, an announcement shall also include
the dates and prices of acquisition and disposal by the related party and
its relationship with the company at the time: Not applicable
7.Matters related to the creditor’s rights currently being disposed of
(including type of collateral of the disposed creditor’s rights; if the
creditor’s rights are creditor’s rights over a related party, the name of
the related party and the book amount of such creditor’s rights currently
being disposed of must also be announced): Not applicable
8.Profit (or loss) from the disposal (not applicable in cases of acquisition
of securities) (where originally deferred, the status or recognition shall
be stated and explained): Not applicable
9.Terms of delivery or payment (including payment period and monetary
amount), restrictive covenants in the contract, and other important
stipulations: Payment will be delivered per the fund-related agreements.
10.The manner in which the current transaction was decided, the reference
basis for the decision on price, and the decision-making unit:
The manner in which the current transaction was decided, the reference
basis for the decision on price：Per fund-related agreements
The decision-making department： The Board of CVCHK and The Board of
CPESH.
11.Net worth per share of company of the underlying securities acquired or
disposed of: Not applicable.
12.The discrepancy between the reference price of private placement company
and the transaction amount per share is 20 percent or more: Not applicable.
13.Current cumulative no., amount, and shareholding ratio of the securities
being traded (including the current transaction) as of the date of
occurrence and status of any restriction of rights (e.g.,pledges):
(1) Current cumulative volume: Not applicable
(2) Amount: up to 5% (inclusive) of the final closing amount of the fund
or RMB 50 million, whichever is lower.
(3) Shareholding percentage of holdings of the security being traded: Up
to 5% of the partnership.
(4) Status of any restriction of rights: None.
14.Privately placed securities (including the current transaction) as a
percentage of total assets of the company and shareholder’s equity of the
parent company on the latest financial statements, and the operating capital
on the latest financial statements as of the date of occurrence:
(1) to the total assets: 0.06% and 0.01%。
(2) to the shareholder's equity: 0.96% and 0.16%.
(3) The operating capital: Not applicable
15.Broker and broker's fee: Not applicable
16.Concrete purpose or use of the acquisition or disposition:
For the needs of investment portfolio expansion
17.Whether the directors expressed any objection to the present transaction: None
18.Whether the trading counterparty is a related party: Yes
19.Date of approval by board of directors: 2021/06/11
20.Recognition date by supervisors or approval date by audit committee:
Not applicable, because the transaction applies to Article 45 of the Financial Holding
Company Act
21.Whether the CPA issued an opinion on the unreasonableness of the current
transaction: Not applicable.
22.Name of the CPA firm: Not applicable.
23.Name of the CPA: Not applicable.
24.License no.of the CPA: Not applicable.
25.Any other matters that need to be specified:
(1) CPESH, a 100%-owned subsidiary of CDIB Capital Group, will set up a
joint venture company (The name has yet decided, and the tentative capital
is up to RMB 10 million contributions of which may be made in several
tranches as needed.) with a 65% shareholding to raise and set up CDIB-
Kunshan Taiwanese Business Fund. The new joint venture company will serve
as the general partner of CDIB-Kunshan Taiwanese Business Fund.
(2) The amount size of CDIB-Kunshan Taiwanese Business Fund is tentatively
set at no less than RMB 900 million. The total investment amount of CVCHK
and CPESH which indirectly invested through the new joint venture company,
will be up to 5% (inclusive) of the final closing amount of the fund or
RMB 50 million, whichever is lower.
(3) These transactions will be submitted to the competent authority for
approval/report under applicable laws and regulations.
(4)The full name of CVCHK is CDIB Venture Capital (Hong Kong) Corporation
Limited；and the full name of CPESH is CDIB Private Equity (China)
Corporation.